Close Menu
GeekBlog

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Patrick Stewart Chose Aquamation Over Cremation. Here’s How Water Cremation Works.

    November 21, 2026

    Garmin Gives Your Dog a Profile: New Watch Update Adds Dog Workouts, Badges and Better Swim Tracking

    November 21, 2026

    Ashton Kutcher Turned $435 Million Into a $7 Billion Anthropic Stake. His Track Record Goes Back to Skype.

    November 21, 2026
    Facebook
    GeekBlog
    • Home
    • Mobile
    • Tech News
    • Blog
    • Gaming
    • Smartwatch
    • How-To Guides
    • AI & Software
    Facebook
    GeekBlog
    Home»Tech News»CRISPR Offers New Hope for Treating Type 1 Diabetes
    Tech News

    CRISPR Offers New Hope for Treating Type 1 Diabetes

    Olivia HartmanBy Olivia HartmanSeptember 11, 2025Updated:October 10, 20265 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
    CRISPR Offers New Hope for Treating Type 1 Diabetes
    Photo: Julia Koblitz on Unsplash
    Share
    Facebook Twitter LinkedIn Pinterest Email Copy Link

    CRISPR gene editing is starting to show real promise against type 1 diabetes. In 2025, doctors in Sweden reported that donor insulin cells, edited with CRISPR so the immune system could not see them, survived and worked in a patient who took no immune suppressing drugs. More than a year later, those cells are still working. Here is what that study showed, who else is in the race and what it does and does not mean for people living with type 1 diabetes in October 2026.

    Quick answer: CRISPR is being used to make insulin producing islet cells that hide from the immune system. Sana Biotechnology’s edited donor cells kept producing insulin in one patient for at least 14 months with no immunosuppression. It is a landmark result, but it involves a single person and a low dose. No CRISPR based diabetes treatment is approved, and larger trials are only beginning.

    The problem CRISPR is trying to solve

    In type 1 diabetes, the immune system destroys the beta cells in the pancreas that make insulin. People then depend on insulin injections or pumps for life. Replacing those cells is an old idea. Transplants of donor islets, the clusters that contain beta cells, can work, and the FDA approved a donor islet therapy called Lantidra in 2023 for certain adults with severe low blood sugar episodes.

    The catch is rejection. Transplanted cells are attacked twice, once as foreign tissue and again by the autoimmune response that caused the disease. That means lifelong immunosuppressive drugs, which raise the risk of infections and other side effects. For most patients, that trade is not worth it. Gene editing aims to remove the need for those drugs entirely.

    What the Sana study found

    Recommended for you:

    How to Watch Coldwater Online: Stream the Andrew Lincoln Thriller
    Tech News·Sep 12, 2025

    How to Watch Coldwater Online: Stream the Andrew Lincoln Thriller

    Researchers at Uppsala University Hospital in Sweden, working with Sana Biotechnology, took islet cells from a deceased donor and edited them with a CRISPR enzyme called Cas12b. The edits removed the HLA class I and II markers that immune cells use to spot foreign tissue and added extra CD47, a signal that tells other immune cells to back off. Sana calls cells like these hypoimmune.

    The cells were injected into the forearm muscle of one adult with long standing type 1 diabetes, with no immunosuppressive drugs at all. The results, published in a major peer reviewed medical journal in August 2025, showed:

    • C peptide, a marker of the body’s own insulin production, appeared in the blood after transplant and rose after meals.
    • Imaging showed the cells surviving at the injection site.
    • No immune attack against the edited cells was detected.
    • No serious adverse events were linked to the treatment.

    In 2026, Sana reported that the cells were still surviving and producing insulin 14 months after the transplant, with no safety issues. That longer follow up was also published in the same journal.

    Watch out: the patient received a deliberately low dose meant to test safety and survival, not to replace insulin. The study was not designed to free the patient from injections, and Sana has not reported that it did. One person is a proof of concept, not proof that a treatment works.

    Who else is working on it

    Sana Biotechnology
    Next candidate SC451 uses hypoimmune islet cells grown from stem cells instead of donors. Sana says it expects to file with the FDA and start a Phase 1/2 trial as early as 2026, with Mayo Clinic as a partner.
    CRISPR Therapeutics
    Earlier tested edited stem cell derived cells inside an implanted device. Its current candidate, CTX213, uses edited stem cells without a device and is moving toward the clinic after animal studies.
    Vertex Pharmaceuticals
    Licensed CRISPR technology for hypoimmune cells in 2023 and lists gene edited islet cells among the approaches it is exploring.

    Vertex also has the most advanced cell therapy overall, zimislecel, but it is not gene edited and still requires immunosuppression. In 2025 it reported that 10 of 12 fully dosed participants with a year of follow up no longer needed insulin injections. In January 2026, Vertex said it had completed enrollment in its pivotal study but temporarily postponed finishing dosing while it reviewed a manufacturing question.

    How the approaches compare

    ApproachImmune drugs needed?Stage in October 2026
    Donor islet transplant (Lantidra)YesFDA approved for a narrow group
    Stem cell islets (zimislecel)YesPivotal trial
    CRISPR edited donor islets (UP421)NoOne patient study
    CRISPR edited stem cell islets (SC451, CTX213)Goal is noPreparing for first human trials

    Stem cells matter because donor organs are scarce. If edited cells can be grown in a lab at scale, one manufacturing process could, in theory, supply many patients.

    FAQ

    Is CRISPR a cure for type 1 diabetes?

    Not yet. The results so far show that edited cells can survive without immune drugs, but no trial has shown that a CRISPR therapy can safely replace insulin for many people over the long term.

    Recommended for you:

    Best Robot Vacuum Mops of 2026: Top Models and How to Choose
    Tech News·Sep 12, 2025

    Best Robot Vacuum Mops of 2026: Top Models and How to Choose

    Can I join a trial?

    Trials are small and have strict criteria. Ask your endocrinologist, who can help you judge whether any study fits your situation.

    When could a treatment be available?

    No company has given a realistic approval date for a gene edited diabetes therapy. Human trials of stem cell versions are only starting, and those usually take years.

    The verdict

    Hiding transplanted insulin cells from the immune system with CRISPR has moved from theory to a working result in a real patient, and that is genuine progress. It is still early, small and unproven at scale. Keep following the trials, and talk to your doctor before making any change to how you manage your diabetes.

    Updated October 2026: covers the Sana hypoimmune islet study through 14 months, the CRISPR Therapeutics and Vertex programs, and where each approach stands.

    Featured photo: Julia Koblitz on Unsplash.

    About this article: GeekBlog covers U.S. technology news, AI, phones, smartwatches and gaming. Every story is written and checked under our Editorial Policy. Spotted a mistake or have a story tip? Contact our editors.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email Copy Link
    Previous ArticleWhy AI Chatbots Tell You What You Want to Hear (and How to Stop It)
    Next Article Blackmagic Camera ProDock: What It Adds to Your iPhone 17 Pro
    Olivia Hartman

      Olivia Hartman is GeekBlog's general technology reporter, covering the wider world of tech beyond smartphones: AI and software, laptops and PCs, gaming, streaming, space, science, consumer gadgets, deals and the policy stories shaping the industry. A versatile journalist with a nose for what actually matters, Olivia turns breaking news and product launches into accessible, no-hype reporting for everyday readers.

      Related Posts

      6 Mins Read

      Patrick Stewart Chose Aquamation Over Cremation. Here’s How Water Cremation Works.

      5 Mins Read

      Ashton Kutcher Turned $435 Million Into a $7 Billion Anthropic Stake. His Track Record Goes Back to Skype.

      7 Mins Read

      Bryan Johnson Says Your Phone Is Hurting Your Eyes. Here’s What His Scans Found and What Actually Helps.

      7 Mins Read

      AI Flagged a Doritos Bag as a Gun and Police Came Armed. Now Four Students Are Suing.

      7 Mins Read

      A Former NASA Physicist Says Reality Only “Renders” When You Look. Here’s How His Parking Lot Theory Holds Up.

      7 Mins Read

      Reporters Had to Bag Their Phones on Air Force One Leaving China. Here’s What a Faraday Bag Actually Stops.

      Top Posts

      Every iPhone Camera Ranked in 2026 (Best to Worst)

      July 6, 2026393 Views

      Apple Watch Black Friday 2026: Early Deals, Prices to Beat and When to Buy

      November 8, 2026219 Views

      Best Browser for Android in 2026: Top Picks Ranked

      July 7, 2026188 Views
      Stay In Touch
      • Facebook

      Subscribe to Updates

      Get the latest tech news from FooBar about tech, design and biz.

      Most Popular

      Apple Watch Black Friday 2026: Early Deals, Prices to Beat and When to Buy

      November 8, 2026422 Views

      One UI 9 Watch: Which Galaxy Watches Get Wear OS 7, and Who Gets Left Behind

      November 6, 2026208 Views

      Garmin Lily 2 Review: Lily 2 vs Active vs Classic in 2026

      November 6, 2026118 Views
      Our Picks

      Patrick Stewart Chose Aquamation Over Cremation. Here’s How Water Cremation Works.

      November 21, 2026

      Garmin Gives Your Dog a Profile: New Watch Update Adds Dog Workouts, Badges and Better Swim Tracking

      November 21, 2026

      Ashton Kutcher Turned $435 Million Into a $7 Billion Anthropic Stake. His Track Record Goes Back to Skype.

      November 21, 2026

      Subscribe to Updates

      Get the latest creative news from FooBar about art, design and business.

      HEICJPG.online - Convert HEIC to JPG online
      Facebook
      • About GeekBlog: Our Mission, Team and Editorial Standards
      • Contact us
      • Privacy Policy
      • Disclaimer
      • Terms and Conditions
      • Editorial Policy
      • Cookie Policy
      • Your Privacy Choices
      © 2026 GeekBlog

      Type above and press Enter to search. Press Esc to cancel.